Shoulder Innovations, Inc. (NYSE:SI) Given Average Rating of “Moderate Buy” by Analysts

Shoulder Innovations, Inc. (NYSE:SI) has been given an average rating of “Moderate Buy” by the seven research firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $20.80.

Several equities research analysts recently commented on SI shares. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Shoulder Innovations in a research note on Friday, January 9th. BTIG Research raised their target price on Shoulder Innovations from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, March 11th. Finally, Weiss Ratings reissued a “sell (e)” rating on shares of Shoulder Innovations in a research note on Monday, December 29th.

Shoulder Innovations Trading Up 0.4%

NYSE SI opened at $14.55 on Wednesday. The business has a 50 day simple moving average of $13.83 and a 200 day simple moving average of $13.79. Shoulder Innovations has a one year low of $10.92 and a one year high of $17.94. The stock has a market capitalization of $300.43 million and a P/E ratio of -0.07. The company has a debt-to-equity ratio of 0.11, a current ratio of 11.07 and a quick ratio of 9.55.

Shoulder Innovations (NYSE:SI) last released its earnings results on Tuesday, March 10th. The company reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.42) by $0.04. Shoulder Innovations had a negative return on equity of 37.68% and a negative net margin of 85.29%.The business had revenue of $14.42 million during the quarter, compared to analysts’ expectations of $12.69 million. Research analysts expect that Shoulder Innovations will post -0.56 earnings per share for the current year.

Insider Buying and Selling

In other news, CEO Robert Joseph Ball acquired 2,200 shares of Shoulder Innovations stock in a transaction on Friday, March 13th. The stock was purchased at an average price of $15.18 per share, with a total value of $33,396.00. Following the completion of the purchase, the chief executive officer owned 278,866 shares of the company’s stock, valued at approximately $4,233,185.88. The trade was a 0.80% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jeffrey S. Points acquired 2,000 shares of Shoulder Innovations stock in a transaction on Friday, March 13th. The stock was purchased at an average cost of $15.00 per share, with a total value of $30,000.00. Following the purchase, the chief financial officer directly owned 70,785 shares of the company’s stock, valued at approximately $1,061,775. This trade represents a 2.91% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 5,200 shares of company stock valued at $78,236 in the last three months. Insiders own 1.71% of the company’s stock.

Institutional Investors Weigh In On Shoulder Innovations

A number of hedge funds have recently added to or reduced their stakes in the company. Sectoral Asset Management Inc. grew its stake in Shoulder Innovations by 14.4% in the fourth quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock valued at $7,042,000 after acquiring an additional 62,153 shares during the period. Deerfield Management Company L.P. acquired a new stake in Shoulder Innovations in the third quarter valued at approximately $6,056,000. Alyeska Investment Group L.P. acquired a new stake in Shoulder Innovations in the third quarter valued at approximately $5,667,000. TimesSquare Capital Management LLC purchased a new position in shares of Shoulder Innovations during the third quarter valued at approximately $4,799,000. Finally, Federated Hermes Inc. purchased a new position in shares of Shoulder Innovations during the third quarter valued at approximately $2,510,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.